RE:RE:Remember thisThat is is one of the reasons why Howie's financial guidance means nothing to investors who have heard it countless times from countless BioTechs. He has been proven wrong on every financial projection so far, why was no update given on the actual R + F revenue vs expected projection on the last quarterly update? We have to wait for the financials, its the only thing in this company that provides actual figures to evaluate this company. Howie could of least provided an estimate on the cost if his super organization changes and/or how he is expected to pay for it all. But no, you think he would learn. Keep the guy to his full time doctor job, hire a business person and remove Howie's decision influence. Do a 5:1 reverse split, provide existing shareholders with a warrant for one additional share at the new price, and Cap the total outstanding shares permitted to be issues for 5 years. Simple.